GC Wealth Management RIA LLC Takes $1.49 Million Position in Teleflex Incorporated $TFX

GC Wealth Management RIA LLC bought a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 1st quarter, HoldingsChannel reports. The fund bought 12,475 shares of the medical technology company’s stock, valued at approximately $1,492,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in TFX. Banque Cantonale Vaudoise lifted its position in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares in the last quarter. V Square Quantitative Management LLC acquired a new position in Teleflex during the 4th quarter valued at about $37,000. UMB Bank n.a. increased its holdings in Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares in the last quarter. Sound Income Strategies LLC bought a new stake in Teleflex during the 4th quarter worth approximately $45,000. Finally, Kestra Advisory Services LLC bought a new stake in Teleflex during the 4th quarter worth approximately $45,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Trading Up 0.5%

Shares of TFX stock opened at $131.86 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The company has a market capitalization of $5.84 billion, a price-to-earnings ratio of -5.78, a PEG ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $139.67. The company has a 50-day simple moving average of $130.85 and a two-hundred day simple moving average of $120.88.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping the consensus estimate of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm had revenue of $548.30 million for the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter last year, the firm earned $1.44 EPS. The company’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Research analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, May 22nd. Teleflex’s dividend payout ratio (DPR) is presently -5.96%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Wells Fargo & Company raised their target price on Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and lifted their target price for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Truist Financial reiterated a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Bank of America raised Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target for the company in a research report on Monday, April 13th. Finally, Raymond James Financial restated an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research note on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $148.00.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.